Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Artificial Nail System Ingredients Approved By EU For Professional Use

This article was originally published in The Rose Sheet

Executive Summary

Use of benzoyl peroxide, hydroquinone and hydroquinone methylether in artificial nail systems is permissible in a professional setting under an amendment to Annex III of the European Union Cosmetics Directive

You may also be interested in...



European Scientific Committee Finds UV Filter, Skin-Lightening Agent Unsafe

UV filter Phenylene Bis-diphenyltriazine and skin-lightening agent deoxyarbutin are not safe for use in sunscreen products (up to 10%) and face creams (up to 3%), respectively, based on submitted and available data, the EC's Scientific Committee on Consumer Safety says. Comments are being accepted through Oct. 23.

FDA Notice Of Proposed Rulemaking On Hydroquinone Slated For June

The Center for Drug Evaluation & Research's Division of OTC Drug Products plans to publish a notice of proposed rulemaking on hydroquinone, a cosmetic ingredient frequently used in skin brightening products, in June, FDA reported in its unified regulatory agenda, published in a Dec. 13 Federal Register 1notice

FDA Notice Of Proposed Rulemaking On Hydroquinone Slated For June

The Center for Drug Evaluation & Research's Division of OTC Drug Products plans to publish a notice of proposed rulemaking on hydroquinone, a cosmetic ingredient frequently used in skin brightening products, in June, FDA reported in its unified regulatory agenda, published in a Dec. 13 Federal Register 1notice

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011573

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel